FeesSafety
Pluang+

Telesat reports Q3 2026 revenue down 20%, signs $2.7B Canadian defense contract for Lightspeed satellites

Company Fundamentals
29 Oct 2026, 14:01 WIB
GlobeNewsWire
View Source
Bearish
Telesat reports Q3 2026 revenue down 20%, signs $2.7B Canadian defense contract for Lightspeed satellites

Telesat announced a 20% revenue decline to $81 million in Q3 2026 and a net loss of $157 million, impacted by lower GEO segment revenue and higher expenses. The company secured a $2.7 billion contract with the Canadian government for its Lightspeed satellite program, expanding its planned constellation to 225 satellites and targeting commercial service by early 2028. Despite financial challenges, Telesat is focused on maximizing GEO satellite cash flow, refinancing debt, and advancing its LEO satellite network with strong government and defense opportunities ahead.

Telesat reported a 20% revenue decline to $81 million in Q3 2026, alongside a net loss of $157 million, as of October 29, 2026. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 29, 2026 17:21 WIB: out of 150 priced US tech stocks, 24 rose and 123 fell. Notable movers include AXTI at USD 60.40 with a 1-day change of -6.18% and Pluang order activity of 57% Sell / 43% Buy, CRWD at USD 250.68 down 5.99% with 74% Sell / 26% Buy, and UMC at USD 17.70 down 5.95% with 46% Sell / 54% Buy.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App